Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OsteoBiologics Inc.

Division of Smith & Nephew PLC
www.obi.com

Latest From OsteoBiologics Inc.

Deal Statistics Quarterly, Q3 2006

In this issue, we present another installment of our quarterly review of dealmaking-for July-Spetember 2006. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.
BioPharmaceutical Medical Device

Building Platforms in Orthopedics

Consolidation has created a widening gulf between small start-ups with innovative technology and large multi-faceted companies that control sales and distribution channels, making life difficult for mid-sized companies caught in the middle. Nowhere is this more true than in orthopedic devices. Now, some investors are finding opportunities in mid-sized companies by using them as platforms to build more substantial plays. The goal isn't market leadership, but value creation for shareholders, which can be done on a more modest scale.
Medical Device Strategy

THM Biomedical Inc.

THM Biomedical Inc. has been quietly fabricating bioresorbable architectures useful in tissue engineering for years. The company begins with a well-known biocompatible material, an amorphous form of polylactic acid, and it creates open-celled three-dimensional architectures that suit a wide range of applications in tissue repair and reconstruction.
BioPharmaceutical Medical Device

The Softer Side of Sports Medicine

Resorbable biomaterials and improved arthroscopic tools form the backbone of innovation in sports medicine, and should, along with the aging baby-boomer population, spur growth in the field
Medical Device Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Smith & Nephew PLC
  • Senior Management
  • Fred B Dinger III, Pres. & CEO
  • Contact Info
  • OsteoBiologics Inc.
    Phone: (210) 690-2131
    12500 Network, Suite 112
    San Antonio, TX 78249
    USA
UsernamePublicRestriction

Register